 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Phase I Dose Escalation Study of Hypofractionated Stereotactic Radiotherapy with Bevacizumab in the Treatment of Recurrent Malignant Glioma
|
 |
San Francisco, CA |
 |
10/08/2012 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 595 in Subjects With Recurrent Malignant Glioma Expressing Mutant Epidermal Growth Factor Receptor Variant III (EGFRvIII) |
 |
Cincinnati, OH |
 |
09/26/2012 |
 |
 |
 |
Details |
 |
A Phase 1 Ascending Dose Trial of the Safety and Tolerability of Tocagen Toca 511 in Patients with Recurrent Glioblastoma Multiforme |
 |
La Jolla, CA Los Angeles, CA San Francisco, CA Detroit, MI Cleveland, OH |
 |
07/16/2012 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Retroviral Replicating Vector (Tocagen Toca 511) to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor |
 |
Los Angeles, CA Detroit, MI Edison, NJ Cleveland, OH Columbus, OH Seattle, WA |
 |
07/16/2012 |
 |
 |
 |
Details |
 |
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma [New concept in treating brain tumors: Interlaced Therapy!] |
 |
Atlanta, GA Baltimore, MD Detroit, MI Winston-Salem, NC |
 |
07/04/2012 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain |
 |
San Francisco, CA |
 |
04/05/2012 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
|
 |
New York, NY |
 |
03/10/2012 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 1 and 2 Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain |
 |
Springfield, IL |
 |
02/26/2012 |
 |
 |
 |
Details |
 |
Phase I Clinical Trial Evaluating Cellular Immunotherapy With Intratumoral Alloreactive Cytotoxic T Lymphocytes and Interleukin-2 for the Treatment of Recurrent Malignant Gliomas |
 |
Los Angeles, CA |
 |
10/27/2011 |
 |
 |
 |
 |
 |
Details |
 |
RTOG 0834: Phase III trial on Concurrent and Adjuvant Temozolomide chemotherapy in non - 1p/19q deleted anaplastic glioma. The CATNON Intergroup trial. |
 |
Houston, TX |
 |
05/11/2011 |
 |
 |
 |
Details |
 |
A Phase I Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide ISA-51VG in Pediatric Patients With Recurrent or Refractory Central Nervous System Tumors |
 |
New York, NY |
 |
03/10/2011 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Trial of Lenalidomide and Radiotherapy in Children With Diffuse Intrinsic Pontine Gliomas and High-grade Gliomas
|
 |
Bethesda, MD |
 |
02/23/2011 |
 |
 |
 |
Details |
 |
A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas
|
 |
Houston, TX |
 |
12/20/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma |
 |
Houston, TX |
 |
12/20/2010 |
 |
 |
 |
Details |
 |
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, followed by Dose Dense Therapy with Temozolomide Plus Bevacizumab (Avastin) for Newly Diagnosed Malignant High Grade Gliomas |
 |
Houston, TX |
 |
12/20/2010 |
 |
 |
 |
 |
 |
Details |
 |
Lenalidomide and Radiation Therapy in Treating Young Patients With Pontine Glioma or High-Grade Glioma |
 |
Bethesda, MD |
 |
11/08/2010 |
 |
 |
 |
Details |
 |
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain
|
 |
San Francisco, CA |
 |
11/04/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas |
 |
Duarte, CA |
 |
10/22/2010 |
 |
 |
 |
Details |
 |
Dendritic Cell Vaccine for Patients With Brain Tumors |
 |
Los Angeles, CA |
 |
09/21/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of PDGFR Kinase Inhibitor (Tasigna® - nilotinib) in Biomarker-Enriched Recurrent Malignant Gliomas
|
 |
La Jolla, CA |
 |
08/17/2010 |
 |
 |
 |
Details |
 |
Study of XL184 in Adults With Glioblastoma Multiforme |
 |
Los Angeles, CA San Francisco, CA Boston, MA Durham, NC Rochester, NY |
 |
07/18/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. |
 |
Rochester, NY |
 |
04/13/2010 |
 |
 |
 |
Details |
 |
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Children with Newly Diagnosed Malignant or Intrinsic Brain Stem Gliomas (BSG) or Incompletely Resected Non-Brainstem High-Grade Gliomas (HGG) or Recurrent Unresectable Low-Grade Gliomas (LGG) or Recurrent High Grade Gliomas |
 |
Pittsburgh, PA |
 |
03/31/2010 |
 |
 |
 |
 |
 |
Details |
 |
2006-0709: Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
 |
Houston, TX |
 |
03/30/2010 |
 |
 |
 |
Details |
 |
2006-0472: Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
 |
 |